These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19289423)

  • 21. Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particles.
    Gedda L; Fondell A; Lundqvist H; Park JW; Edwards K
    J Nucl Med; 2012 Mar; 53(3):480-7. PubMed ID: 22323773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
    Costantini DL; Bateman K; McLarty K; Vallis KA; Reilly RM
    J Nucl Med; 2008 Sep; 49(9):1498-505. PubMed ID: 18703606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells.
    Hoang B; Reilly RM; Allen C
    Biomacromolecules; 2012 Feb; 13(2):455-65. PubMed ID: 22191486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular routing in breast cancer cells of streptavidin-conjugated trastuzumab Fab fragments linked to biotinylated doxorubicin-functionalized metal chelating polymers.
    Liu P; Cai Z; Kang JW; Boyle AJ; Adams J; Lu Y; Ngo Ndjock Mbong G; Sidhu S; Reilly RM; Winnik MA
    Biomacromolecules; 2014 Mar; 15(3):715-25. PubMed ID: 24506198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
    Kairemo KJ; Tenhunen M; Jekunen AP
    Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle.
    Liang M; Liu X; Cheng D; Liu G; Dou S; Wang Y; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2010 Jul; 21(7):1385-8. PubMed ID: 20557066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.
    Chen L; Wang Y; Cheng D; Liu X; Dou S; Liu G; Hnatowich DJ; Rusckowski M
    Bioorg Med Chem; 2013 Nov; 21(21):6523-30. PubMed ID: 24054488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trastuzumab Labeled to High Specific Activity with (111)In by Site-Specific Conjugation to a Metal-Chelating Polymer Exhibits Amplified Auger Electron-Mediated Cytotoxicity on HER2-Positive Breast Cancer Cells.
    Ngo Ndjock Mbong G; Lu Y; Chan C; Cai Z; Liu P; Boyle AJ; Winnik MA; Reilly RM
    Mol Pharm; 2015 Jun; 12(6):1951-60. PubMed ID: 25919639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
    Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
    J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.
    Liu G; Dou S; Pretorius PH; Liu X; Chen L; Rusckowski M; Hnatowich DJ
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):333-40. PubMed ID: 20639818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y; Sadhukha T; Ma L; Panyam J
    J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
    Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance.
    He J; Liu G; Vanderheyden JL; Dou S; Mary R; Hnatowich DJ
    Bioconjug Chem; 2005; 16(2):338-45. PubMed ID: 15769087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
    Liu Y; Franzen S
    Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.
    Liu G; Dou S; Mardirossian G; He J; Zhang S; Liu X; Rusckowski M; Hnatowich DJ
    Clin Cancer Res; 2006 Aug; 12(16):4958-64. PubMed ID: 16914585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.
    Liu G; Dou S; Baker S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
    Cancer Biol Ther; 2010 Oct; 10(8):767-74. PubMed ID: 21099368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell uptake and radiotoxicity studies of an nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]+.
    Haefliger P; Agorastos N; Renard A; Giambonini-Brugnoli G; Marty C; Alberto R
    Bioconjug Chem; 2005; 16(3):582-7. PubMed ID: 15898725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity.
    Hanaoka H; Katagiri T; Fukukawa C; Yoshioka H; Yamamoto S; Iida Y; Higuchi T; Oriuchi N; Paudyal B; Paudyal P; Nakamura Y; Endo K
    Ann Nucl Med; 2009 Jul; 23(5):479-85. PubMed ID: 19412654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.